Medscape

📞 Calling future #cardiology leaders! We have a few spots left in our Resident/Fellow Scholarship Program. Remaining spots include complimentary registration only and access to our resident and faculty lunch on Sunday, January 26. Apply today or share with a friend! 👉 http://ms.spr.ly/6184ouU7Y #HeartofCardio

💥 ICYMI! Robert Harrington, MD led a chat asking, do we another anticoagulant?! Roxana Mehran, MD explains that more complex patients presenting with high ischemic burden and high bleeding risk creates an overlapping treatment dilemma that Factor XI, a novel anticoagulant, may be able to help solve. with Geoffrey Barnes, MD WATCH THE DISCUSSION ➡️ http://ms.spr.ly/6043o848U

Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease management. - - - - Moderator: Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI Faculty: Geoffrey D. Barnes, MD, MSc Faculty: Daniella Kadian-Dodov, MD, FACC, FAHA, FSVM, RPVI - - - - Earn free 0.25 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event. Click the link to view the Accreditation and Disclosure details before participating: https://lnkd.in/e5NGK2gt. Supported by an independent educational grant from Janssen Pharmaceuticals.

🩸 Do not miss this 𝐋𝐈𝐕𝐄 #𝐀𝐇𝐀𝟐𝟒 𝐫𝐞𝐜𝐚𝐩 𝐢𝐧 𝟏 𝐇𝐎𝐔𝐑 as renowned faculty review key insights re: thromboembolic disease prevention and management. ➡️ http://ms.spr.ly/6042W7ysr

𝐓𝐡𝐞 𝟑 𝐒’𝐬 𝐟𝐨𝐫 𝐌𝐀𝐒𝐋𝐃/𝐌𝐀𝐒𝐇: S- Screen for MASLD/MASH 🧪 S- Stage patients with MASLD/MASH 🖥️ S- Start appropriate treatment 💉 Learn more about MASLD/MASH: http://ms.spr.ly/6045oz8L7

Tackling NF1-Associated PN Barriers: Cynthia Campen, MD with Matthias Karajannis, MD review the treatment algorithm by age, role of surgery, and when to initiate MEK inhibition. Watch their insightful discussion ➡️ http://ms.spr.ly/6040WAh2n

Stroke prevention with anticoagulation is imperative, but bleeding risk is a common problem. Could factor XIa inhibition be the solution? Manesh Patel, MD Professor of Medicine Chief, Division of Cardiology Duke University School of Medicine Durham, North Carolina, United States Ashkan Shoamanesh, MD Associate Professor of Medicine (Neurology) McMaster University / Population Health Research Institute Hamilton, Ontario, Canada Earn free 0.25 AMA PRA Category 1 CreditTM. Access for credit will be shared at the end of this live event. Click the link to view the Accreditation and Disclosure details before participating: https://lnkd.in/ei-6KHqk Supported by an independent educational grant from Bayer.

Join Dr. Jeff Gudin as he discusses the goals of analgesic treatment and understanding what’s important in acute and chronic pain. http://ms.spr.ly/6047oMfbV

𝐖𝐀𝐓𝐂𝐇 𝐋𝐈𝐕𝐄 𝐢𝐧 𝟏 𝐇𝐎𝐔𝐑!! ➡️ http://ms.spr.ly/6046W71Kq 🩸 Factor XIa inhibition offers a promising approach to stroke prevention, balancing the need for anticoagulation while addressing the challenge of bleeding risks.

Moving the Needle in ER-Positive/HER2-Negative Metastatic Breast Cancer: Exploring SERD Strategies to Optimize Outcomes